Pharmacokinetics&Pharmacodynamics Flashcards

1
Q

is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion (ADME).
•How body handles the drug

A

Kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects.
•Effect of drug on body

A

Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient

A

Clinical pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What factors influence drug absorption (8)

A
Molecular wt 
Blood flow 
Solubility 
Concentration 
Disintegration and dissolution 
Partition coefficient 
Transporters 
pH partition theory (Henderson-Hasselbalch)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sublingual route?

A

Nitroglycerine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rectal routes?

A

Antiemetic
Opioids
BZ
Antipyretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pulmonary routes?

A

Beta agonists
Anti muscarinic
Volatile anesthetics
Corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Faster or slower onset for drugs with high pKa (low pH)

A

Faster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why are pro drugs used?

A

Improve how the intended drug is absorbed, distributed, metabolized, or excreted (more soluble to create parenteral form or improve oral absorption)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

-lack intrinsic efficacy. Classically pretreatment with this reduces the maximum response (Emax) – they diminish maximal efficacy
functioning to remove receptors from the system (since they can not be recovered by administering agonist)
-bind to the same receptor site as an agonist but they dissociate very slowly (or not at all) from the receptor site. Covalent binding is frequently involved and no displacement of this by an agonist is possible

A

Irreversible competitive antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What kind of efficacy does an agonist display?

A

Positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • to a receptor at the same site as the agonist normally binds. This binding prevents the agonist from binding. Competitive antagonists are also described as surmountable.
  • shifts the log dose response curve for a full agonist to the right (a parallel shift) – note that the maximum response possible (Emax) is unchanged if sufficient agonist is given to overcome this. The ED50 is increased however.
  • can be displaced (surmounted or overcome) if sufficient agonist is administered
A

Reversible competitive antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of efficacy does an antagonist display?

A

Zero

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What kind of efficacy does an inverse agonist display?

A

Negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What 2 properties do partial agonists have?

A
  1. Produce max response (which is weaker than tissue max)

2. Capable of ‘displacing’ full agonist (antagonizing it)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

agonists bind to a receptor and produce a molecular response with a subsequent cellular response

A

Full

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

agonists bind to a receptor BUT even the highest drug concentration is incapable of producing a sufficient molecular response to generate the cellular response seen following administration of a full agonist

A

Partial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

agonists have a higher binding affinity for a receptor in the resting state than in the active state (unlike antagonists which bind equally at both states). They abrogate the intrinsic constitutive activity of the free unoccupied receptor

A

Inverse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What determines to a large dress the quantitative relationship between drug dose and pharmacological effect?

A

Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

relates drug dose to the size of the response in a single individual
•It also reflects the maximal efficacy of a drug

A

Graded dose response relationship

21
Q

relates drug dose to the proportion of individuals displaying a desired pharmacologic response
•It also reflects the variability of responsiveness among individuals

A

Quantal dose response relationships

22
Q

What can both graded and quantal dose response curve show us?

A

Potency and selectivity of drug action

23
Q

relative term which represents the amount of one drug required to produce a desired level of effect to the amount of a different drug required to produce the same effect (observe EC50 or ED50)

A

Potency

24
Q

relative term which represents the amount of one drug required to produce a desired level of effect to the amount of a different drug required to produce the same effect

A

Efficacy

25
Q

What is a special case of tolerance (acute tolerance)

A

Tachyphylaxis

26
Q

Hyporeactivity resulting from chronic drug exposure. Clinically cross-tolerance is common between drugs producing similar pharmacologic effect

A

Tolerance

27
Q

How can drug absorption be described?

A

Extent of absorption (total amount entering systemic)

Rate of absorption (how quickly drug enters systemic)

28
Q

Common drugs with relevant first pass clearance (4)

A

Ca channel blockers
Beta blockers
Diuretics
Lidocaine

29
Q

How do you inspect rate of absorption?

A

Tmax and Cpmax

30
Q

How to you inspect extent of absorption?

A

AUC

31
Q

Fraction absorbed into the systemic circulation is the drug’s what?

A

Bioavailability

32
Q

Describes how a Substance distributes itself between 2 immiscible solvents

A

Partition coefficient (absorption and distribution)

33
Q

What links drug concentration to the amount of drug in the body?

A

Apparent volume of distribution (V)

34
Q

Inactive precursors that are metabolized to active metabolites

A

Pro drugs

35
Q

What phase of metabolism is CYPs mainly for?

A

Phase I

36
Q

Expect a decrease in elimination rate constant of object drug - increased half life

A

Inhibition

37
Q

Expect increase in elimination rate - decreased half life

A

Induction

38
Q

Larger or small inhibitors encountered in clinical practice?

A

Larger

39
Q

Larger or smaller number of inducers are encountered in clinical practice?

A

Smaller

40
Q

What kind of stereoisomers is etomidate?

A

R(+)

41
Q

What kind of stereoisomers is bupivacaine?

A

Local anesthetic, Na channel blocker

42
Q

What kind of stereoisomers is ketamine?

A

Race mate

43
Q

How to calculate volume of distribution

A

Dose/resulting concentration

44
Q

used when it is desirable to rapidly establish a therapeutic concentration of drug in the body, instead of waiting for the drug to accumulate from a series of maintenance doses.

A

Loading dose

45
Q

When does elimination begin?

A

as soon as first drug molecule enters the central compartment

46
Q

as soon as first drug molecule enters the central compartment

A

First order rate kinetics

47
Q

A constant amount of drug is eliminated per unit time regardless of the amount of drug in the body

A

Zero order rate kinetics

48
Q

What is the half life equation?

A

.693/ke